2020 MELANOMA - MCKEAN - Combination Immunotherapy vs Monotherapy for Metastatic Melanoma
GRACE is excited to bring you a new series on current updates in Melanoma Treatment
Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma service at Memorial Sloan Kettering and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.
In this video, Dr. McKean discusses combination immunotherapy vs. monotherapy for Metastatic Melanoma.